CPhI Announces 2014 Expert Panel and Report

Article

CPhI 2014 panel additions to provide global insights from the contract services sector.

CPhI Worldwide has announced its confirmed expert industry panel members for 2014. This year’s panel sees the return of ten thought leaders with the addition of three new members, covering the entire pharmaceutical supply chain from R&D through to finished products, regulatory requirements, and economic implications.

Additionally, this year panel members are using their market insights and analysis year-round in the CPhI Pharma Insights series, which covers individual topics and developments across the industry including the released R&D, manufacturing, and Turkey reports, with a US report due out soon.

The new panel members are all from the contract manufacturing arena, including: Alan Armonstrong, CEO and Douglas Cookson, VP corporate marketing from Almac; Hendrik Baumann, CEO of Arevipharma; and Lukas Utiger, president of fine chemicals and integrated offering at DSM. Collectively they provide a global overview of outsourcing, with Almac and Arevipharma focusing on the international market from a European stance and DSM from a US perspective.

The returning members include Girish Malhotra, Sam Venugopal, Piramal’s Vijay Shah, Hedley Rees, Prabir Basu, Dilip Shah, Emil Ciurczak, and William Botha.

The 2014 annual report features a collection of in-depth essays from each panel member, with experts predicting how the industry will look and operate in the future from both an economic and practical perspective.

Source: CPhI Worldwide

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
David Fairen-Jimenez
Industry Outlook 2025: The Rising Prominence of AI in Pharma
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.